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THE SPECIFIC CONSTITUTIONAL TREATMENT OF CANCER

A REVIEW

by

lUURICE L. PEPPER

OMAHA, NEBRASKA

APRIL, 1936

PREFACE
The physician and medical student may have heard
mention of constitutional methods of treatment of cancer.
Such methods are seldom referred to in textbooks or classrooms, but are occasionally presented at medical meetings,
especially those primarily interested in the study of
malignant disease.

The infrequent and sometimes casual

references made to the subject will fail to impress one
of t ts scope, ancl of the immense amount of work whi ch
has been done in an attempt to find a therapia magna
sterilisans for cancer.

Furthermore, one who presents

posi ti ve findtngs is apt to omi t reference to n"nmerous
studies which have yielded negative results and thus
leave his audience with a distorted outlook on the subject.
It is, therefore, to orient the student tm this field of
cancer research, to survey a large group of methods and
substances proposed for the specific constitutional
treatment of cancer, and to reach some conclusions as
to their value, potential and. attained, that this paper
is written.
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THE SPECIFIC CONSTITUTIONAIJ

TRl'~ATMENT

OF CANCER

I

INTRODUCTION
SCOPE. --Thj.s paper is a review of the treatmt;nt of cancer
by substances and methods which are introduced into the
body distal to the tumor and which exert a specific
deleterious action, directly or indirectly, upon the
cancer cell, resulting in regression of the tumor and
cure of the affected patient.

Included are chemicals,

gland and ttsslle extracts, bacteria and their growth
products, body flutds, toxins, ana a number of physical
methods.

While certain immunologic methods are of this

general nature, they are not inclucled here because of
some rather fundamental differences in the problems
involved and because the subject is so voluminous as to
merit a special study of its own.

It has recently been

thoroughly reviewed by 'Noglom (1929) and Caspari (1929).
Obviously excluded from consideration by the stated scope
of this paper are methods of prevention of cancer, treatment by dietary restrictions, and treatment by removal
of organs of internal secretion.

Numerous publications

have, from time to time, accepted a method of constitutional
treatment which was a current favorite and described it
without citing observations regarding its value, but as
this is written with some view to estimating the value
4 --

of proposed methods, such publications are not considered
here.

Quacks have often employed constitutional methods

to treat cancer patients but are deserving of no consideration.

GENERAl, CONSIDERATIONS OF CANCER BEARING

on

TREATMENT.--

A tumor is defined by Ewing (1922) as an autonomous new
growth of tissue.

Such growths subserve no useful function

and are largely uncontrolled by the organism.

Tumors

are divided into benign tumors and. malignant tumors or
cancers.

The latter group consists of those tumors which

exhibit certain features which are essentially deleterious
to the host, most important of which are lnflltrative
growth, local destruction of tissue, recurrence after
removal, formation of metastases, local interference with
functlon, and general toxlc action of absorbed tumor
products.
There are numerous theorj.es as to the cause
or causes of cancer, but no general single cause has as
yet been proven.
well known:

The following theories are particularly

the embryonal rest theory of Cohnheim, the

tissue tension theory of Ribbert, the theory of tissue
growth of Adami, irritation, heredity, metabolic derrangement, and specific parasite.

Most of the theories are

not entirely satisfactory because the postulated cause
cannot be shown to operate in a majority of the cases of
cancer and because the cause can be present without
-- 5 --

.",

resulting in cancer.

Often a supposed cause has later

been shown to be only a phenomenon which is part of the
capcer process itself or which is secondary to the neoplasm.

It has become necessary, therefore, to suppose

a multiplicity of factors to be involved, varying in
different cases,--some are exciting and some are predisposing, some are general and some are local, some acquired,
some hereditary.

If cancer is a parasitic disease (there

is much evidence to show that it is not), it is important
from the point of view of treatment to determine whether
the continued presence of the parasite is necessayy for
the continued growth of the malignant cells once the
process has been initiated (Boyd, 1925).
Regardless of the cause of cancer, it is generally accepted that the process is itself specific, the
growing cancer celIs constituting, as it were, an invading
"orga,nism!l.

The cells are specific in their property of

unlimited and unrestricted growth as a result of perversion of norMal functional and nutritive relations.

The

energy for excessive growth is liberated by abnormally
excessive carbohydrate cleavage (Warburg, 1931).

Other

properties of cancer cells are atypical structure, increased
permiability, abnormal lipid relations, electrical reactions,
response to calcium salts and intracellular water content,
and excessive co-ferment primary in the cleavage of
dextrose (Eggers, 1932).

Factors contributing to the
6 --

increased reproductive capacity are inherent growth
energy, heredity, hormonal imbalance, and, probably
of greatest importance, factors as yet unknown.
The well known property of cancer to invade
and metastasize, which often renders local treatment
incomplete, makes a specific constitutional method of
treatment desirable.

With all treatment at the present

time consisting of local excision or destruction, the
best medical skill attains only about fifteen percent
of definitive cures for all types of cancer (Haagensen,
1933).

Failures result from incomplete removal.

While the percentage of cures will undoubtedly be
improved by earlier diagnosis and improved technique, it
can never approach the results to be attained with a
successfulconsti tlltional form of treatment.

The

importance of this field, therefore, lies jn the treatment
of cases advanced beyond the hope of successful surgery
or irradiation and in prophylaxis against recurrence
following excision or destruction.
At present, there is no method proven successful in any high percentage of cases.

The methods attempted,

however, will be reviewed and their results evaluated.
SPECIFIC CONSTITUTIONAL TREATMENT.--A large number of the
methods reviewed here may be classed as chemotherapeutic.
Some of the specific constitutional methods, however,
such as the use of hormones and bacterial growth products,
-- 7

could only

que~tionably

be called chemotherapeutic,

while others, such as fever therapy, in no sense fall
into this realm.

The attempt is to review all methods

not specifically excluded.
Chemoth rapy, as stated, does playa large
part in the speci ic constitutional treatment of cancer.
Barger (1930) def nes chemotherapy as the use of drugs
on which chemical work has been done, usually synthetic
substances, alkal ids or their derivatives, in the treatment of parasitic disease, acting by its toxic effect
on the specific c
states that in th

agent.

Kolmer (1926), however,

modern sense chemotherapy includes the

treatment of para itic disease by more or less specific
disinfection of

tissues without marked or serious

toxic effect on t e host.

The chemotherapeutic agent

need not necessar ly be monoparasitotropic and it may
act indirectly by production of leukocytosis, stimulation
of phagocytosis

0

upon the parasite

other immune defense as well as directly
He discusses such fundamental concep-

tions as parasito ropism and organotropism, chemotherapeutic index, lea sand chemoreceptors.
Kolmer

1926) considers the use of chemotherapy

in cancer as depe dent upon the etiology of cancer:
if due to a chang

in cells resulting from prolonged

irritation, a substance which will destroy the cells
nroduced must be found; (2) if due to specific virus
-- 8---

(1)

alone, discover a specific destructive chemical agent
for it; (3) if due to chemical irritation, chemotherapy
could not remove it; (4) if clue to irritation produced
by a specific or non-specific organism, the chemotherapeutic substance would have to destroy the organism
causing the irritation and the cells already changed.
Findlay (1930) regards the cancer cells as specific;
any chemotherapeutic method must destroy all the cancer
cells by its direct lethal action upon the malignant
cells, by destruction of the blood vessels to the tumor,
or by stimulation of defensive and fixed tissue cells.
The first of these possibilities, direct destruction of
the tUMor cells, is ideal, but very difficult because of
the great similarity of cancer cells to normal cells.
The metabolic difference detected by Warburg is suggested
as an important basis for rational therapy.
GENERAL CONSIDERATION OF THE METHODS.--The many substances
and methods which have been proposed for the specific
constitutional treatment of cancer may be classified as
follows:

(1) metals and metallic compounds; (2) other

inorganic compounds; (3) other organic compounds; (4)
a miscellaneous group of substances including hormones
and tissue extracts, bacteria and their growth products,
toxins, and body fluids; and (5) physical methods,--fever
therapy, gas inhalation, and modification of fluid balance.
The usual dose of the substance employed is
-- 9

sufficient1y large thq,t its toxicity is of great importance,
although a few are used in relatively non-toxlc doses.
Since highly toxic doses of substances are dangerous,
their use is impractical and they are without value.
Every known Method of administration has been used, but
since the effect of intratumoral injection may not be
constitutional, repnrts of such treatment are not included.
~lbjects

for the investigation of proposed

remedies have been animals bearing various types of
experimental cancer and human inoperable cancer.

Objec-

tion has frequently been raised to reports based upon
the use of one type only of animal tumor and to the
use of transplantable tumors.

Provided the experiments

are properly controlled and the animal work is used only
to get leads as to posstble value in treatment of human
cases, no valid objection can be raised.
The substances and methods used have produced
a great variety of local and general effects.

Some

observers have gone to great lengths to describe in
minute detail these changes.

For our purposes, such

descriptions serve only to cloud the true results, for
we are interested here only in destruction of the cancer
and cure of the victim.

Because of the results of their

experiments, most observers reach some conclusions as to
the value of their form of treatment.

These are given

where they have been made and discussed later in the
10 --

light of certain criteria.
Weil, who was one of the early workers in the
field of chemotherapy in cancer, sought some basis for
evaluation of the results of his experiments and those
of others.

He concluded (1913) that "the demonstrable

reduction in size of a tumor, of a kind not to be attrib11ted to the natural processes of evolution of that tumor
or of its associated lesions, is the one essential feature
of effective therapeutic intervention."

By way of ex-

planation and expansion, it may be stated that this
refers to established, proven Malignant tumors, that
they must be reduced in size and metastases must not
clevelop, anct that the natural process of evolution of
the tumor and its associated lesions must be noted in
untreated controls and conclusions based upon differences
in the two sertes.

Furthermore, that the remedy may

be constdered specific, it must be effective in a
significant percentage of the cases treated.

In human

cases, the percentage of five year cures computed according
to the rules laid down by the cancer commission of the
health organizatton of the League of Nations (1929)
constitutes a second necessary criterion for the evaluation of the results of treatment.

The above are reasonable

and necessary yardsticks, yet the majority of investigators
in thls field are unaware of the necessity of basing their
conclusions on these or any other guides.
-- 11 --

THE SPECIFIC CONSTITUTIONAL TREATMENT OF CANCER
II
HISTORY
CANCER.--The history of our knowledge of cancer is divided by Ewing (1922) into four periods.

The first of

these began in the earliest times and lasted until
about 1661.

The earliest medical documents, the Papyrus

Ebers, about 1500 B. C., refers to tumors in general,
but there is no clear reference to cancer.

Lipoma is

clearly described,--it is treated "with the knmfe".
Hippocrates (460-375 B. C.) knew cancer 'well and
described many forms.

He advised against treating

deep-seated lesions; only cautery and various caustic
pastes were recommended.

Galen (130-201 A. D.) made

no significant contribution to the knowledge of

~ither

the cause or treatment of cancer; his work is important
only because his authority was so great that he crystallized medical thought and obstructed progress in the
investigation of cancer until after the Renaissance.
The humoral pathology by which deficiency or excess of
bile, blood or mucous formed the basis of all disease
disseminated conceptions of the ortgin of cancer and
prevented progress for near}y two thousand years.

In

his classification, Galen included many inflammatory
lesions, localized edemas, gangrene, and other affec-- 12 --

tions which he could not understand with true tumors.
attributed cancer to an excess of black bile.

He

Local

treatment of cancer improved somewhat, but the ideas as
to the nature of the disease remained about the same
until the lymph theory of Ma1phigi began the second
period in our knowledge of cancer in 1661.
Harvey discovered the circulation of the
blood in 1628; Olens discovered the lymph vessels
in 1652; Malphigi discovered the red blood corpuscles
in 1661.

Lymph coagulated and foamed on boiling, hence

cancer was composed of lymph varying in density, alkalescence or acidity.

Galen's doctrine was demolished.

The lymph theory dominated thought until 1852.

Morgagni's

work in 1761 constituted the beginning of pathology and
the beginning of the description and fl.lassification
of cancer.

Schwann showed that all living matter was

composed of cells in 1838, and Johannes Muller founded
microscopic pathology at about this time, but held to
the lymph theory.
It remained for Virchow in 1858 to begin the
histologic period of our knowledge of cancer with his
dictum "omnis cellula e cellulaf!.

Virchow believed that

all malignant tumors arose heterologously from connective
tissue.

Thiersch corrected this in 1865 by changing

Virchow's dictum to !Tomnis cellula e cellula ejusdem
generis".
-- 13 --

The present period in the study of cancer is
the experimental period, which began with the Twentieth
Century.

It began with the successful transplantation

of a spontaneous carcinoma of the vulva of a rat to the
testis of several male rats by Hanau in 1889.

Jensen

carried a mouse carcinoma through nineteen generations
in a classical study in 1903.
CHEMOTHERAPY. -- "From the earliest times hea:1ers of the
sick have sought specific remedies in the" form of drugs
or methods that would always and unfailingly cure the
effect of a certain disease" (Kolmer, 1926).

Many

substances have been used and mostly discarded.

At the

beginning of the modern era, there were only three of
proven value,--mercury for syphilis, since 1500, and
cinchona bark for malaria and ipecacuanha for dysentary,
since the Seventeenth Century.
Modern chemotherapy began with Ehrlich who,
stimulated. by Heubel on lead poisoning. idealized "that
the ways and means by which

d~lgS

are distributed over

the body must be of great importance in the rational
development of therapeutics." ·His work with the arsenica1s in the treatment of syphilis began the modern era
of rational chemotherapy.
CHEMOTHERAPY IN CANCER.--Constitutional methods have been
used in the treatment of cancer since earliest times.
Cato administered charcoal

an~
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variety of crude internal

remedies were mentioned by Pliny.

Avicenna (980-1037)

administered arsenic internally.

Fabricius (1537-1619)

experimented with various internal remedies.

With the

decline of Galen's authority in the Seventeenth Century,
treatment was demoralized; arsenic and other internal
remedies were abused.

Helmont and Ettmuller thought

cancer due to an excess of acid and treated it with
alkali.
tone.

Hoffman applied his anodyne to restore tissue
Goulard used a lead preparation, lead subacetate,

locally in 1760.

Torres first used colloidal metals in

1904 (see Waters, Colston and Gay, 1929).
The rational investigation of the application
of specific constitutional Methods of treatment to cancer
depended primarily upon the existence of a rational
chemotherapy as founded by Ehrlich.

Experimental methods

of cancer research, while not absolutely essential, were
very desirable, and were most important for the investigation of the value of a large number of substances in
the specific constitutional treatment of cancer.
The modern history of the specific constitutional
treatment of cancer began with the use of killed cultures
of streptococcus

ery~ipelas

in the treatment of animals

bearing spontaneous neoplasms by Spronck in 1892 and
with the use of the mixed toxins of Streptococcus erysipelas and Bacillus prodigiosus in the treatment of human
cases of inoperable malignancy by Coley in 1893.
-- 15 --

The first

wo~k

with chemotherapy proper was

that of Wassermann, Keysser, and. Wassermann, reported to
the Berlin Medical Society in 1911.

They treated mice

that had been innoculated with transplantable tumors
with an eosin-selenium compound, thinking that the
eostn would carry the toxic selenium into the cancer
ce lIs.

They be Ii e,red that they haa. cured a few animals,

but their preparation was soon shown to be without value.
Their work, however, had attracted wide attention and
others were led to

8i~ilar

attempts.

Leob, et aI, in

this country, reported on the use of copper compounds
in 1912.
For the most part, the subsequent history of
the speoific constitutional treatment of cancer is the
history of the use of the individual s11bstances and.
methods which have been proposed.

-- 16 --

THE SPECIFIC CONSTITUTIONAL TREATMENT OF CANCER
III
METALS AND METALLIC COMPOUNDS
Metals have played a most important role in
the treatment of cancer.

Where they have been used, the

action of the compound has been, for the most part,
ascribed to the effect of the metal.

Whether or not

the action of the substance is in every case due to the
metallic constituent, such an assumption serves as a
convenient basis for classification.

Caspari (1928)

theorizes as to the action of all heavy metals.

He

believes they increase the autolytic processes of cells,
all thus having a general harmful effect on tumors.
The colloidal form has been believed especially useful
for various reasons, probably the most valid of which
is the idea that metals are less toxic in such form
than in compounds in which the metal is ionized.
Before constdering the tndtvidual metals, it
seems desirable to discuss four papers which have each
reported upon the use of a large number of metals and a
few non-metals in the therapy of tumors in animals.
Ishiwara (1927) investigated the effect of compounds of
fifty-eight different metals upon mice bearing the Bashford carcinoma No.63.

He divided these substances into

four groups on the basis of their effect.
-- 17 --

All the metals

to be mentioned later with the exception of sodium,
potassium and chromium were included in the tests.

To

test the validity of the positive results reported by
Ishiwara, Simpson and Marsh (1931) and Marsh (1934)
investigated the effect of one hundred nine compounds
upon albino mice bearing spontaneous mammary adenocarcinoma.

They included all the metals of Ishiwara's

series except praseodymium, niobium, ytterbium, and
terbium (the latter three were classed as effective by
Ishiwara).

All the substances mentioned later in this

paper except praseodymium were included in one of these
papers.

Not one of the one hundred nine compounds em-

ployed showed any evidence of therapy, macroscopic or
microscopic, upon the tumor or its growth.

All three

papers include substances which are not cons5. dered later
because the only reference to· the use of such substances
in the treatment of animal or human tumors is in these
papers.

The results of Maxwell and Bischoff (1931) were

negative for all substances employed on the rat sarcoma
No. 10 except praseodymium nitrate.

With the Hyde rat

carcinoma, all their results were negative.
LEAD.--Goulard introduced lead for the local treatment
of cancer in 1760, but it was not until the work of W.
Blair Bell in 1922 that attention was called to its
possible constitutional use.

Bell had observed the

frequency with which spontaneous abortion occurred in
-- 18 --

women employed in the lead industry.

He reasoned that

this was due to a specific harmful effect exerted by the
lead upon the embryonal cells such as occur in the chorionic villi.

Cancer cells resemble those of the chorionic

villi in their primitive structure and invasive tendencies,
and should,
lead.

there~ore,

likewise be harmfully affected by

Furthermore, on the basis of the work of Bullock

and Cramer (1913-14), who showed that certain transplantable tumors of the mouse and rat had a tendency to a
higher content of phosphatids and cerebrosides than normal
tissue and that the content was higher in rapidly growing
tumors than the more slowly growing ones, Bell argued
that the action of the lead consisted of a combination
with the lecithin of the tumor cells.

Of thelr numerous

communications, several have dealt solely with these
theoretical considerations and their experimental proof
(Bell et all, 1925).

Other investigators have contended,

however, that lead acts on the vessels of the tumor.
Animal Tumors.--Wood (1926) used colloidal
lead on a group of nine hundred white rats bearing a
transplantable carcinoma and two transplantable sarcomas,
all highly virulent.

The tumors were greatly affected,--

there was extensive necrosis in most, but all but a few
recurred.

A very few (number unstated) were completely

absorbed.

Wood believed that the lead caused thrombosis

of the newly-fo:rmed., fragile vessels of the tumor.
Girard (1927) found lead to be the best of a group of
-- 19 --

metals applied by electrical endosmosis to a spindlecelled rat sarcoma, causing absorption which was sometimes complete.

Veachi (1930) used twenty-five albino

rats implanted with osteoid sarcoma; there were twentyfour takes.

Using nine as controls and dividing the

remainder into three groups of five, he found that the
treated animals had smaller tumors at every observation
period over a period of forty days except the first (fifteen days).

Wood (1927), in a later work, found that

colloidal metallic lead combined with irradiation was
more effective on the rat sarcoma no. 10 and on the
Flexner-Jobling rat carcinoma +.han either lead or irradiation.

Dextrose failed to increase the effectiveness

of either the lead or irradiation.

The Jensen rat

sarcoma was uninfluenced by lead salts injected intramuscularly in oil (LeGuyon, 1931).

Eggers (1934)

treated animals inplanted with the FRC carcinoma and
the R39 rat sarcoma with lead salts of acids derived
from a group of hexose sugars in an attempt to utilize
the metabolic peculiarity of cancer cells discovered by
Warburg.

While the glycuronate, galactonate and gluco-

heptonate were successful in a few cases, Eggers considered
his results with these compounds unsatisfactory.
Mottram (1928) investigated the effect of
combined lead and irradiation on mouse carcinoma T63.
(Tumors disappeared following combined therapy in snch
-- 20 --

doses of each as would be ineffective alone.

He concluded

that the action was a summation of the effects of each;
also tha-t the sllbstances acted upon the vessels of the
tumor, partly by secondary radiation, and that the
results were sufficiently encouraging to warrant
in human cases.

tr~al

Krause, and later Collier, have under-

taken the investigation of a number of organic lead
compounds in an effort to modify the toxicity of the
product and maintain its therapeutic potency.

Krause

(1929) first reported upon the investigation of a group
of such compounds on mice with experimental carcinoma.
n-propyl lead flouride (n-C3H7)3PbFl was especially
effective in the prophylaxis and treatment.

Collier

(1929) tested Krause's compounds on mice two hours after
innoculation with the Ehrlich carcinoma.

While all

of three hundred controls died in four to stx weeks,
the treated animals frequently showed no growth Whatever,
or growth to a small size with later regression.

Best

results were wtth n-propyl lead flouride and tetraphenyl lead.

In 1929, Collier also investigated the

effect of fifteen inorganic and

org~nic

lead salts on

transplantable mouse tumors, most of which inhibited
growth in twenty to thirty percent of the cases.

The

best results were with the tannate, oxalate, malate,
and citrate, and especially with the formate, which
retarded nearly sixty-five percent and caused the dis-- 21 --

appearance of thirty-five percent.

Collier and Krause

(1931) treated mice with solutions of heavy metal compounds two days after innoculation with the Ehrlich
carcinoma.

Most active were K(PbC1 3 ) and K(Pb 2C1 ).
5
Krebs and Clemmesen (1934) gave R237b (see below) to
one hundred mice with Krebs 2 carcinoma, a tumor that
has not yet receeded spontaneously.

There was no differ-

ence in the controls and the treated animals.
Collier (1932) found the potassium salt of
plumbo-dithio-pyridincarboxylic acid, called R232, to
retard the growth of the Brown-Pearce rabbit carcinoma,
and to prevent the development of metastases.

While

Krebs and Clemmesen had some succeas with this compound
and its sodium salt (R237h) on the Brown-Pearce rabbit
carcinoma and in leukoses of fowls, they found the latter
of no value in a monse tumor.

While Bell published his

first paper on the treatment of cases of human malignant
disease in 1922, it was not untll 1935 that his organization investigated the value of lead compounds in the
treatment of animal tumors.

At that time, a group of

twenty-seven organic lead compounds were tested by the
Liverpool Medical Research Organization under M. Datnow.
The Brown-Pearce rabbit carcinoma was used, and of the
twenty-seven compounds, seven were entirely unsuitable
because of their toxiCity and five had been only partially

,-

tested.

Some of the others will be used in human cases.
-- 22 --

Results following the use of manganese combined
with lead phosphate on rats with sarcoma 39 lead Kraemer
(1931) to advocate the use of this combination in cases
of human cancer.

Marsh and Simpson (1927) treated female

albino house mice bearing spontaneous mammary carcinomas
with lead tetra-ethyl.

It had no effect except in lethal

doses.
Dilling (1928) and a number of other observers
have reported coneentration of lead in tumors.

Reinhard

and Buchwald (1929) treated mice bearing spontaneous
mammary carcinoma:s of various duration with varied
doses of lead colloid.

They examined they tumors spec-

troscopically and by two chemical methods and could find
no lead whatever in the tumors.
Human.--Bell employed various preparations
of colloidal metallic lead.

A colloidal preparation

was used because it was thought to be less toxic than
other compounds.

His first paper (1922) set forth the

theoretical consid.erations upon which the work was based
and gave the results of his early clinical experiments.
Inoperable cases were selected and, while none were
refused, it was though t that the patient should be able
to live six months without treatment to be a good risk.
Lead was found in the tumors in considerably greater
concentration tha:n in the other tissues and was thought
to increase the sensitivity to irradtation.
-- 23 --

As much of

the growth as possible should be excised to prevent
toxic absorption and to reduce the amount of treatment
necessary.

Fifty cases were treated over a two year

period and four of the thirty-five receiving a complete
course of treatment were considered cured.

Two of these

had been treated '"i th lead alone and two had combined
irradiation and lead therapy.

Reports on the progress

of his work were made by Bell and his co-workers in
1924, 1925 and 19:29.

The 1929 report, which is the

last one made (Be 11 died early in 1936)

t

include s a

total of 566 case:s, treated over an eight year period
ending in November, 1928.

Of these, 450 died; 22 dis-

continued treatmeYlt; 12 were completely arrested; 51 were
believed cured anll treatment stopped; and 31 were recent
cases.

Thus, of the 315 having adequate treatment, 63,

or twenty percent, had satisfactory

resu~ts.

Slightly

over ten percent of the whole series had satisfactory
results.
Follwwi:ng the work of Bell, Stone and Craver
(1927) treated six cases successfully wtth colloidal

lead out of a total of twenty-one.
bone tumors.

Four were primary

A case of chorioepithelioma was unaffected.

Wood (1928) treated forty patients who had inoperable or
recurrent malignancy.

Four were living and well after

a year with no sign of neoplasm, and the tumors had completely disappeared in two others that died of inter-- 24 --

current disease.
were used.

Colloidal metallic lead and irradiation

Rume (1928) treated thirteen cases with

Bell's preparation S7 alone with no improvements, but
noted improvement in two of seven cases in which irradiation was combined with the lead.

Soiland, Costalow, and

'Meland (1928) treated a series of eighteen cases and
arrested one case of carcinoma of the cervix which had
previously been treated with radium for an unspecified
length of time.

Knox (1929) treated forty patients, of

which four were well and wholly free of all signs of
cancer at the end of a short period of observation.
Brunner (1929) reported definite improvement of an unstated nature in seven of fifteen patients.
co~pleted

Brunton (1930)

the treatment of thirty-four patients with S7.

There were two clinical cures of a duration of three
years.
O'Crowley (1926) treated two cases of epithelioma of the penis with colloidal metallic lead.
unaffected.

They were

Talbot (1928) failed to cure two cases of

cancer but thinks their lives prolonged.
noted no effect on twenty cases.

Hey (1928)

Eight cases of Kaemmerer

(1928) received adequate dosage without being in any way
improved.

Wyard (1928) reported on fifty-six cases

treated at the Cancer Hospital, London, with one good
result in an unproven lymph node recurrence of a cancer
of the breast.

From his own observations, he concluded
-- 25 --

that lead is of no use in the treatment of cancer, and
from other reports available at the time, he concluded
that there was no reason why lead should be of use and
no evidence that it is.

All of the seventeen cases treated

by Schreiner and Wende (1929) died or metastases occurred.
The results of Mattina (1930) on twenty cases were similar.

Da~imier

and Schwartz (1934) treated seven cases

with a colljodal metallic lead preparation and seventeen
cases with lead phenylamy1acetate.

The end results in

these cases were unchanged, and the authors concluded
that the treatment had been without value.
Colloidal lead phosphate has had considerable
vogue in treating malignant disease.

Ullmann (1928)

reported two cases greatly improved out of a series of
cases treated.

In a later report (1929) on fifty-seven

cases, five had responded favorably and five were too
recent for evaluation.

Osterberg, Horton, Bargen, and

Rankin (1932) treated ninety-five cases with colloidal
lead phosphate at the Mayo Clinic.

Of the forty-eight

cases receiving what the authors considered adequate
treat~ent,

twenty-six died and twenty-two were living

at the time of the writing, six months to two and one
half years after beginning treatment.
free of all signs of neoplasm.

Nine were clinically

In a later series of

eighty-one cases treated, for the most part, with combined
lead and irradiation (1935), sixty are known dead,
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seven are either not traced or are known to have recurrences, and thirteen are living and cltnically well after
at least two years.

Of the latter group, seven received

lead alone and six received lead and irradiation.
about sixteen percent were successfully treated.

Thus,
Aub

and Smithwick (1933). however, treated twelve patients
who were in relatively good condition despite the presence
of an inoperable neoplasm, using combined lead and itradiation, and not only failed to attain any successful
results but felt that the patients were made worse and
their duration of life shortened by the treatment.
Sojland, Costolow and Meland (1929)

li~ewise

failed to

cure any of thirty-one cases with the combined treatment.
Other lead preparations have been used, and
some have tried several lead preparations, or lead and
some other substance, in a series of cases.

Thomson

(1928) used colloidal lead (choriotrope), lead glycine
and lead phosphate in a group of fifty-five cases.

Six

were too recent for evaluation, while only five were
improved.

Coke and Cook (1926) experimented with several

lead. compounds and apparently cured one case wi th lead
and. XTray.

Dentici, Moratti and Pattarin (1929) treated

twenty-five cases with a lead. preparation.

Two which had

not been biopsied completely regressed, three partially
regressed, sixteen died, and seven had not comp!eted the
treatment.

Waters, Colston and Gay (1929) had poor
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results with two series of cases in which a lead compound
had been combined with irradiation.

Costa (1930) treated

seven oases with lead "Dezani ff , a proprietary preparation,
with no cures.

Sohlurch (1933) treated thirty-two Oases

of inoperable oarcinoma with lead iodide in caleium
gluconate solution and noted no objeotive improvement
attributable to the lead in any oase.

Simpson (1928)

treated nineteen oases with a lead preparation.
died and the other one was unimproved.

Eighteen

Colloidal lead

oxide was used by Loewy and Loiseleur (1928) in the treatment of twenty-one oases.

Looalization of the lead in

the t 11mor was noted and arrest of clevelopment of the
tumor was thought to oocur in four cases.

A later report,

however, faileC! to confirm the early favorable results
(1928).

Fry (1928) found no histologioal changes in

growths treated with lead not observed in untreated tumors.
Todd and his assooiates (1928) worked with
compounds of lead and selenium, based on previous olaims
of value in eaoh.

Their first report on forty-four

oases treated with colloidal lead selenide (D4S) recorded
no cures, but retardation of growth occurred in eight
oases and twenty-five died.

They warned against the use

of this substanoe oombined with irradiation (1929).

In

1930. Todd reported on the progress of his work, and in
1934 the last available report was made.

He believes that

the treatment stimulates the natural body defense against
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invasion by the

c~ncer

cells.

The original preparation,

D4S had proven unsuccessful and the use of it (liscontinued
in favor of selenium preparations containing no lead.
COPPER.--Copper compounds were among the first SUbstances
to be widely tried experimentally for the chemotherapy
of cancer.

Loeb began j.ts use in this country in 1912,

while a group of observers were favorably impressed in
Europe.
Animal Tumors.--Loeb (1913) used a group of
preparations of colloidal metallic copper in mixture with
casein and claimed to have cured a few mice bearing a
transplantable adenocarcinoma.

Next, a group of substan-

ces"including platinum, sulfur, lanthanum, and ethylhydrocuprein, were tried in compination with .colloidal
copper (Loeb and Fleisher, 1913).

All were ineffective.

Of a group of proteins, casein and nucleoprotein alone
were effective, but no cures resulted.

Finally, colloidal

copper and colloidal copper combined with casein or
hirudin were found to inhibit the growth of nine to
thirteen day old mouse carcinomas, being more effective
in smaller, more rapidly growing tumors than in larger,
more slowly growing ones, these results being reported
by Fleisher and Leob in 1914.

Heuberg, Caspari and Lohe

(19l2) were unable to find tumor cells in mice cured by
a copper preparation of spontaneous and transplantable
tumors.

Their later work failed to confirm these good
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results.

These authors proposed the theory that since,

according to Petri, tumor cells had increased Quantities
of autolytic ferments, and according to Tzar, colloidal
metals increase the activity of autolytic ferments,
therefore, the colloidal metals
enhancing autOlysis.

a~fected

cancer cells by

This theory has never been confirmed.

Szecsi (1912) was unable to attain satisfactory results
with colloidal copper.

Keysser (1914) found. that while

the colloidal copper glycine of Neuberg cured some cases
of subcutaneous innoculated tumors of mice, it was of no
value whatever in infiltrating tumors and metastases of
organs.

Cells of a transplantable tumor suspended in it

in vitro grew when implanted into new hosts.
Human.--Loeb et al (1912) began the use of
colloidal copper in cases of hUman cancer in May, 1912.
Their report, made in December, as well as one made early
the following year, on nineteen cases treated with colloidal
copper, noted improvement in most cases, especially those
of slow growing tumors without too extensive metastases.
No cures were claimed.

McClurg, Sweek, Lyon, Fleisher,

and Loeb (1915) treated a group of cases of non-keratizing
cylindrical-celled
cancer of the skin and a group of cases
..
of squamous-celled cancer with their copper-casein preparation.

Detailed case reports were given, but no cures

of cases of proven malignancy were claimed.

Weil (1913)

treated twelve cases of cancer with colloidal copper,
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eight of whieh completed the treatment; he stated that
every improvement except destruction of the tumor occurred, an 0. concluded that it is of no value in any case.
Soiland, Costolow

an~

Meland (1927) noted no effect in

four cases treated by intramuscular injections of colloidal copper.
SILVER. --Animal Tumors. --}Teuberg t Caspari, and Lohe (1912)
found colloidal silver to be espeCially valuable in treatment of transplantable and spontaneous tumors of mice.
Silver preparations were marketed under the names of
fulmargin and electrargol.

Rohdenberg (1915) used colloidal

silver and leci thin in phenol soluti. on to treat mice with
the Ehrlich careinoma.

His experiments were controlled

with mice that were untreated as well as by those treated
with silver and lecithin alone.

One series showed slight

benefit to all those treated over the untreated animals;
variation in the percentage of the constituents had no
effect.

Treatment

ha~

no effect whatever, however, on

animals bearing the Croeker Fund mouse careinoma No.5.
Walburn (1930) treated 130 miee bearing tar tumors with
d51ute solutions of silver nitrate.

There were fourteen

eomplete regressions.
Human.--No favorable results have been reported
in the treatment of human cancer with silver preparations.
Rohdenburg (1915) treated ten cases with colloidal silver
and lecithin, all of which had had tissue diagnosis.
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All

the patients d.ied.

Stone, Pack and Woodard (1930) used

a preparation of colloidal silver prepared similarly to
colloidal lead.

There was no alteration in the course

of the disease in the patients treated.
BISMUTH.--Anir:1al Tumors.--Zadik (1930) claimed successful
results in the treatment of a transplantable sarcoma of
the rat with a bismuth preparation, Bismuth Yatren A,
combined with isamine blue.

Ishiwara (1927) found

bismuth ammonium tartrate to be the only one of twenty
metallic compounds successful in inhibiting the growth
of the Flexner rat carcinoma.
Human.--The success of Zadik in treating human
cases with his mixture was reported at first as being only
temporary.

In a later report (1930) on the treatment of

109 cases with isamine blue and bismuth (Wismut Yatren A,

an

or~anic

acid containing bismuth and iodine), he claimed

definite improvement in thirteen cases observed up to
two years.

Kahn and Wirth (1927) treated ten cases with

colloidal bismuth (Wismut-Diasporal 360', in solutihon with
d.extrose, and. X-ray.

Their report at the end of a year

claimed some beneficial results.

Lasch and Neumann (1929)

treated eighteen cases by Kahn's method, and noted an effect
only in those cases in which X-ray was also used, but even
here the results were poor.
MAGNESIUl!.--Animal Tumors.--Delbet and Pallios (1928) claimed
that transplantable tumors in an unstated number of mice
-or
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were retarded in growth by oral and subeutaneous administration of magnesium compounds.

Bolaffi (1930) treated.

rats bearing an adenocarcinoma with magnesium chloride
subcutaneously and orally and found only very slight
prolongation of life as compared with controls and
reduction of the size of the tumor in only certain instances.
The magnesium content of the tumors was not altered, but
the calcium to potassium ratio was increased in some
instances.

A later report (1930) on the use of magnesium

iodide and magnes:!.um phosphate combined, or the latter
alone, concluded that magnesium has no inhibitory effect
on the growth of carcinoma of the rat and is of no value
in treatment.

Shear (1933) made an extensive revlew of

the literature and carried on numerous experiments of his
own ln a study of the role of magnesium in cancer, approaching
the problem

fro~

the standpoint of the content of the

blood and the tumor of magnesium and the effect of its
use in treatment.

He concluded that there is some

Question as to its value in the treatment of cancer but
that the retarding effect claimed for it certainly does
not exist, and that no points are sufficiently established
to warrant clinical trial.

Sugiura and Benedict (1935)

studied the influen.ce of magnesium on the growth of carcinoma, sarcoma, and melanoma in animals.

They found that

aa.ministration of very low magnesium diets to animals after
growth of transplantable tumors became established had
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no marked inhibitory effect on the tumors, that very high
magnesium diets slightly accelerated growth of tumors but
that more regressions occurred, and that prolonged use
of a high magnesium diet in animals with established
F1exner-Job1ing rat carcinomas, mouse sarcoma 180 and
the Passey mouse melanoma did not check the growth of the
tumors.
Human.--Schrumpf-Pierron (1931) believed that
lack of intake of sufficient magnesium to be a cause of
cancer.

He attempted to show that cancer is about ten

times as frequent in Europe as in Egypt and held that
this is due to the fact that the soil of Egypt contains
fj.fteen to seventeen times as much magnesium as that of
France.

Ernst (1932), however, was unable to report any

cures among fifty-four patients treated by irradiation
and a complex preparation containing magnesium.

Craig

(1934) used magnesium chloride with apparently good results
in one case of carcinoma of the larynx observed over a
period of only a few months.

Cure was not claimed.

Wright (1934) reported on four cases treated with magnesium sulfate; benefit was thought to have resulted
from the treatment but no cure was claimed.
GOLD.--Anima1 Tumors.--Lewin (1913) used colloidal

~old,

gold potassium cyanate and other gold salts in the treatment of animals with malignant growths.

There was some

effect, which Lewin attributed to action on the young
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capillaries of
easily injured.

tu~ors,

which he thought particularly

Fleisher and Loeb (1914) treated mice

with carcinoma with colloidal gold and gold potassium
cyanate, with little effect.
Human.--Ochsner (1926) reported very favorably
on the use of pure colloidal gold suspended in pure water
in the treatment of cases of inoperable cancer.

He

gave case reports on five cases, one of which was alive
and well after an interval of about four years.

He

sent questionaires to 182 physicians who had treated a
total of 309 cases with colloidaJ gold.

Six were reported

cured and ninety-seven were too recent for opinion.

Thus,

out of 212 cases having sufficient treatment, six, or
about three percent, were claimed cured.

Soi1and,

Costolow and Meland (1927) treated an unstated number of
cases of inoperable cancer with colloidal gold by mouth
with no effect.
ANTIMONY.--There have been no reports on the use of

th~s

metal in animal tumors, but Minervini (1928) reported
on the use of a combination of antimony tartrate and
extract of ipecac root given by vein and intratumora1ly
in cases of inoperable human cancer.

At the time, he

gave no results, but a later communication (1929) described
th~

results in 141 cases of carcinoma and fourteen cases

of sarcoma, all proven histologically.

The preparation

used was a solution of all the alkaloids of ipecacuanha
wtth the addition of anitmony potassium tartrate, a preparation he called Antiblastoma L.

He discouraged the

use of irradiation with this treatment.
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He claimed that

I
I

,

in about one third of the cases arrest of the growth with
decrease in size and sclerotization occurs.
observed cases up to two years.

He has

Cestaro (1930) used

Antiblastoma L in two cases and claimed one and two year
cures.

Pattarim (1931) found Minervini's preparation to

be of no value in any of twenty cases.
RADIOACTIVE ELEMENTS.--Animal Tumors.--Spies (1931)
treated mice innoculated with the Twort carcinoma with
uranium nitrate and thorium nitrate.

The tumors grew

faster in the forty treated animals than in the forty
controls, due, Spies thought, to the stimulating effect
of radioactive substances.

Burrows (1934) treated rats

bearing the Jensen sarcoma with a diverse group of substances, including thorium, gelatin, and alum.

A higher

percentage of retrogressions occurred in those treated
by any method than in the untreated animals.

The author

believes this due to the fact that many things affect the
host and result in reduced vigor of tumor growth, yet
have no therapeutic value.

He points out that conclusions

based on the weight of the tumor are fallacj_ous, as
well as those based solely upon grafted tumors.

He con-

siders good results with the more reliable grafted tumors,
such as the Crocker Fund mouse sarcoma 180, an indication
for later use on spontaneous tumors before trying on
human cases.
Human.--Hocking (1928) used the feebly radioactive substances uranium and thoriUm in an effort to
combine the local effect of radium and the general effect
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of lead and yet avoid the purely local action of radium
and the toxic effect of lead.

He treated thirty-one cases

with these substances in colloidal solution and claimed
improvement in seventy percent.

One case of cancer of

the breast with metastases is alive and well after
twelve months.

Pack and Stewart (1930) treated eight

cases with Hocking's preparation in an effort to check
his results.

One was slightly benefitted but his life

not prolonged, while the other seven were not benefitted
in any way.
MISCELLANEOUS METALS.--A number of metallic preparations
enjoyed early popularity in the constitutional treatment
of cancer but have since been shown to be without value
or it has been discovered that the original results
failed to establish any true value.

Szecsi (193:2) found

that a selentum-vanadium compound was the most active of
the group of substances he employed in the treBtment of
mice with transplantable tumors.

Keysser (1914), however,

showed that while superficial tumors were cured, the
substance was entirely inactive in treatment of infiltrating tUMors of the organs and that it had no effect
upon the tumor cells in vitro.

Neuberg, Caspari, and Lohe

(1912) claimed success in the treatment of animal tumors
with cobalt and with platinum, the latter having also been
investigated by Fleisher and Loeb (1914).

Kolmer (1926)

included tin among those metals which had had early
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popularity but which had no sUbstantial claim to effectiveness.

Krause (1929) investigated the effect of a group

of complex organi c compound_s of tin on roi ce wi th experimental carcinoma to
therapeutic effect.

determ~_ne

the toxici ty an(l chemo-

Regression of the tumor was noted

in a small persentage of cases with two of the four
compounds used.
LeGuyon (1931) found potassium chromate, sodium
chromate, chromium phosphate, and basic alumj_num acetate
ineffective in treatment of the Jensen rat sarcoma.
Ernst (1932) used a preparation containj_ng lithium,
magnesium and iodine, called RIll, in the treatment of
fifty-four cases; no cures were claimed.

Engman (1932),

thinking that thalllum acetate might affect young, actively
growing cells, treated thirteen groups of five to fifteen
rats each with the Flexner-Jobltng carcinoI!la in a well
controlled eXT)6r4I!lent.

No effect occurred.

Lansbury (1932)

used the sarle tumor ana. found no effect from thallium
phosphate, acetate and iodide.

Gardner (1928) had good

results with titanium employing a compound derived from
the action of titanium chloride on a lipase solution
combined with sodium oleate.
Shear (1933) made an extensive review of the
role of potass5_um, sodium, calcium, and magnesium in
cancer.

He concluded that:

sodium had no effect upon

cancer, potassium may have a slight stimulating effect,
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calcium possibly slightly retards the growth of cancer;
the effect of magnesium has already been noted.

In

a later report, Shear (193'3) noted that he was unable to
affect the tumor cells with calcium.
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SELENITTM.--Animal Tumors.--Selenium was the first substance to be used in the chemotherapt of cancer.
Wassermann noted the staining of cells by eosin and combined it with selenium in the hope that the toxic selenium
would be carried to the malignant cells by the eosin.
Experiments with the substance upon transplantable and
sponmaneous rat tumors gave results which Wassermann
considered suffictently successful to report at a meetine
of the Berlin Medical Society (Wassermann, Keysser, and
Wassermann, 1911).

Following this report, there was wide

comment upon the possibilities of the sUbstance (Editorials, 1912).

Wassermann, however, had made no great

claims concerning the efficacy

o~

his preparation, and

his report failed to state the toxicity and the percentage
of animals treated. succe ssfully.
S00n a number of observers attempted to confirm
this work.

Uhlenhuth (1912), however, found that a group

of compounds of selenium and various dyes had no effect
on mouse and rat tumors, and Walker (1912) was unable to
prepare an effective compound.

Finally Keysser (1914),

one of the partners in the original work reported by
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Wassermann, founel that the substance cured only a very
low percentage of animals, that it was very highly toxic,
that it had no effect on such small tUmors as were not
apt to undergo spontaneous central necrosis, that it had
no effect on infiltrating tumors of organs or on metastases, and, finally, that it was totally ineffective
in destroying tumor cells in vitro.
Human.--Following the early work on animals,
several commercial selenium products were tested in
cases of inoperable human cancer,--electro-se1enium,
seleniol, sulpho-selene, etc.

Results were reported by

a number of observers, symptomattc improvement betng
noted in the preliminary reDort of each in PloSt cases.
Follow-up reports stating the final results in these
cases, however, have never been published.

Watson-

Williams (1919) sUffiTl",arized a group of these preliminary
reports and was so favorably impressed that he employed
a preparation called erythro-selenium beta in twentyfour cases.

He observed these a short time and listed

improvements noted in nineteen cases, but he has not
reported on their final outceme.
After giving up the use of D43, a compound of
lead and selenium, Tod.d (1934) investigated a number of
selenium compounds not containing lead.

He used two

substances in each case of inoperable cancer treated
since May, 1931. One was prepared from selenium dioxide
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and colloidal sulfur, called SSe, and always followed
its administration with irradiation, claiMing that
the radient energy caused "ionizationf! of the SSe and
thereby enhanced its value.

The other substance, which

was alternated with SSe, was selenium and SOMe feebly
radioactive substances, radium G and traces of higher
breakdown products, prepared to form a colloidal solution
called R. A. S.

This latter preparation produced regres-

sions in twenty-five percent of tumors in animals bearing
a slow-growing strain of the Twort carcinoma.

The first

series consisted of ninety-three cases treated from May,
1931 to September, 1932.

Eighteen discontinued treatment,

five were recent cases, three were cured but died of
intercurrent disease, and fifteen are living and well and
have been discharged as cured.

The second series included

all cases treated from Septernber, 1932 to date, numbering
sixty-two in all.

Twelve were recent cases, seven discon-

tinued treatment, three were discharged as cured., and nine
were under treatment and doing very well, some awaiting
discharge.

There are, then, about twenty percent cures

in each series.
ARSENIC.--There are very few references to the use of
arsenicals in the tre9tment of cancer.

In view of its

extensive use in the treatment of syphilis, this is
difficult to explain.

It seems probable that there were

numerous early attempts to use arsenic in cancer but,
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I

'

these beine failures, were not reported.
Animal Tumors.--Uhlenhuth (1912) used

a~number

of arsenio preparations in the treatment of cancer in animals and found that stimulation of growth oocurred.
Eggers (1934) investigated the effe·ot of compounds of
arsenio and aoids derived from a group of hexose sugars
on the FRC oarcinoma and the R39 rat sarcoma of the
Crocker Institute.

There haa been previous attempts by

several observers to employ metabolic peculiarities of
the cancer cells as a basis for chemotherapeutic attack.
Eggers used the abnormal carbohydrate metabolism discovered by Warburg (1931), by which an abnormal affinity
or an altered mode of utilization of carbohydrates
occurs in cancer cells.

~e

employed sugars as carriers

of toxic radicals in an effort to effect the elective
intoxication of the cancer cells.

While a compound

containing a toxic redical attached to the side chain of
the dextrose molecule would be theoretically best, there
is no method at present of preparing such substance, so
he was restricted to compounds of acids derived from
sugars and tetramethyl arsonium as the toxic radical.
Tetramethyl arsonium gluconate was the only suocessful
oo~pound.

In eleven rats with the FRC caroinoma, five

tumors completely disappeared, while four of ten with the
R39 tl'mor d j sappeared.

Next insulin was administered wi th

the arsenical to temporarily diminish the available
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supply of glucose in the blood.

Tumors in nine of twelve

animals with small FRe tumors completely disappeared,
while five of six slightly larger tumors disappeared.
Tumors in twenty-one of twenty-two animals with small
R39

tumors disappeared, while four of twelve larger ones

disappeared.
were treated.
i~plants.

None disappeared when very large tumors
The only regularity was with three day

The toxicity of the compound is very low.
Human.--Dreuschuch and Lovas (1926) reported

two cases of ovarian carcinoma treated by X-raY,!l group
of hormones and an arsenic preparation, with both patients
alive and well two years.

Eggers has treated several

cases of human inoperable cancer wtth tetramethyl
arsonium gluconate, but he considers·the work too reeent
for evaluation of results.
SULFUR.--Animal Tumors.--Izar (1913) proposed colloidal
sulfur for the treatment of trnplanted rat sarcoma.

He

found that rapid regression followed its intravenous use.
Small tumors receded entirely, while large tumors became
necrotic and deRth of the animal frequently followed,
supposedly due to absorpti0n of the toxic material liberated from the tumor cells.

Zagni (1927) used a colloidal

sulfur preparation called sulfosolo on a group of mice
with experimental carcmnoma and sarcoma.

Two of the

sarcomas disappeared, and some success was claimed wlth
the carcinoma, but :i.n no case was the total number of
animals used given.
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Human.--Cignozzi (1927) treated nearly one
hundred cases with oral and intravenous administration of
colloidal sulfur and noted some decrease in size of a
few tumors.

Surgical treatment and pre- or post-operative

irradiation were combined in some cases.
MISCELLANEOUS.--Tellurium, because of its similarity to
selenium, has been used experimentally in the treatment
of cancer.

Wassermann, Keysser, and Wassermann (1911)

seemed much less impressed of its value than that of
selenium.

Uhlenhuth (1912) found tellurium and iodine

compounds to be of no value in treatment of rat and mouse
tumors.

Rossi (1928) believed sodium silicate necessary

for cicatrization and sclerotization, and that when employed
with other methods of treatment might be valuable in
aiding the natural defense of the organism.

The results

of his use of this substance are inconclusive.

Wog1om

and Weber (1934) employed heavy water in doses equal to
120 times the usual daily intake of heavy hydrogen,
given subcutaneously, intraperitoneally, and intravenously
saY-co"",'"

in mice with .carcinoma 180 and carcinoma 63.
no effect on the host or tumor.

There was

Ishiwara, Marsh, and

Simpson and Marsh, in papers previously referred to,
included the use of a number of the inorganic substances
reviewed above in their work.
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Benedict and Lewis (1914) reported some success
in treating experimental tumors with toxic doses of
phloridzin.

Wood and UcLean (1916) were unable to dupli-

cate their findings on mice with spontaneous mammary
carcinoma, the Crocker Fund mouse sarcoma 180, and the
Buffalo rat carcinoma using non-toxic doses of phloridzin.
Results with the first two tumors were about the same in
the treated animals as in the controls, while with the
Buffalo rat sarcoma, fewer tumors in treated animals were
absorbed than the untreatec. controls.

Werner (1912)

found rat tumors reduced in size after injection of
choline borate subcutaneously.

He later switched to a

mixture containing choline borate, which was found to be
entirely without value.

Fleisher and Loeb (1914) exper-

imente<d. with casein, nucleoproteid, and hirudin, which
they thought caused some inhibition of growth of the
tumors employed.
Karczag et al (1927) treated mice innoculated
with the Ehrlich carcinoma with convulsive doses of
potassium cyanide.

They thought that this respiratory

poison might have some selective effect on malignant
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cells, based on the metabolic peculiarities discovered
by Warburg.

In ninety-eight

m~ce

treated, fourteen were

cured, while none of forty-five untreated controls lived.
:Maxwell ana. Bischoff (1933) tested hydrocyanic acid on
several tumors of rats and mice.

In several series of

mice with sarcoma 180, the rate of growth in the seventyone controls was slightly greater than in the sixty treated
animals.

The rate of growth of tumors in rats with

carcinoma 256 and sarcoma RIO appea.red to be slightly
decreased.

There were no significant differences in the

number of takes and the number of regressions

~el1h.l'1delhn

mice bearing sarcoma 180 between those treated with
carbon monoxide and the untreated controls.

Perry (1935)

found that prolonged inhalation of cyanide arrests body
growth in young rats and retards the growth of the Jensen
rat sarcoma.

While a considerable percentage showed

complete regression, the compound was very toxic.
A few of the amino acids have been tried.
Vles and. his co-workers (1930) gave a mixture of alanine,
cystine and proline to 107 mice with tar cancers following
biopsy.

Twenty-six disappeared, thirty-seven partially

regressed, thirty-five remained stationary, and nine were
unaffected.
trols.

There were no regressions in forty-two con-

A series of twenty mice were treated with a

mixture containing two molecules of d-glutamic acid to
one of cystine.

Ten disappeared and six partially regressed.
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In a later paper (1934), they reported on the use of
amino acids (l-cystine, d-l-alanine, and d-I-proline)
combined with dried powdered tissues.

MRre mamIllary

carcinomas regressed than when amino acids were used alone.
Fifteen of the thirty-eight tumors disappeared.

In another

report, however, they stated that the cured animals
died sooner than others, due to breakdown of tumor tissue.
Gilroy (1930) found that a transplantable mouse tumor
was unaffected by glycine, alanine, eystine, eysteine,
glutamic acid, sodium valerate and histidine.

Argenine

stimulated growth.
Marsh (1933) treated spontaneous Illouse carcinomas
with ethyl alcohol by intraYenous, subeutaneous, and oral
administration and by these methods in combination.
None of the forty-niRe treated animals showed any curative
effect.

Nakahara (1924) found that while sodium oleate,

oleic acid, linolic acid and linolenic acid increased the
resistance of mice to subseq.uent innoculation wi th the
Bashford adenoaarcinoma 63, there was no marked influence
on established grafts.
Krontowski et al (1932) attempted to inhibit
glycolysis of tumor cells with monoiodoacetic acid and
monobromacetic acid.

These compounds were effective in

vitro but failed to retard the growth of the Ehrlich
mouse carcinoma or the Jensen rat sarcoma in intact
animals in doses consistent with the effective concen-- 48 --

tration in vitro.

Seele and Bodansky (1935) thought

that similar substances having a greater permiability
might be more effective.

They treated rats bearing

sarcoma 39 with relatively large doses of bromcaproic
acid.

Daily doses given for four weeks proved fatal

to thirty to forty percent of the animals and had no
specific inhibitory effect on the tumor.
Amoroso (1935) treated mice bearing carcinoma
63 with small quantities of colchicine.

Two-thirds of

the tumors of some series disappeared and all of those

An epithelioma of the buccal

in other series regressed.

mucous membrane in a dog disappeared on treatment.
DYES
ISAMINE BLUE.--Animal Tumors.--This dye has been used by
a nUJ!lber of experiMenters in the treatmen.t of inoperable
human cancer since it was introduced by Roosen in 1923.
Marsh and Simpson included it in a report on 145 coal
tar dyes and their antecedents used in the treatment of
albino house mice with spontaneous carcinoma of the
breast.

Practically every dye ever used to treat cancer

is included in the list, and none subsequently mentioned
in this paper were omitted.
entirely negative.

The results were uniformly

Zadik (1930) claimed success in the

treatment of transplantable rat carcinoma with pure
isamine blue and bismuth.
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Human.--Roosen (1923) observed some concentration
of isamine blue in tumors.

He argued that since the dye

is very easily reduced in the body, injection of some
very easily exidizable substance following administration
of the dye might lead to formation of deleterious substances,
in the tumor cell.

The easily oxidizable substance

selected was neosalvarsan.

The two were administered

alternately at intervals of several days.

The author claims

good results, especially on small skin cancers.
were found more susceptible than carcinoma.
tumors responded poorly.

Sarcoma

Internal

Irradiation destroyed the power

of the tumor of absorbing the dye.

Bernhardt, and Bern-

hardt and Strauch (1928) reported on eighteen cases
treated with isamine blue.
and eight were not

i~proved.

Five regressed, ten improved,
Roosen, in 1930, advocated

isamine blue alone rather than combined with bismuth
ot irradiation, and has published a book summarizing the
work done by a group of observers.

Karrenberg (1929)

had no regressions in five cases, and ZadikTs results
on human cases were only temporary.

Nyka (1931) included

isamine blue in a review of nine dyes used in the treatment of cancer and concluded that it was of doubtful
value.
MISCELLANEOUS DYES.--Copeman (1928) reported on five
cases of inoperable carcinoma of the breast, one of which
completely disappeared under treatment by "activated"
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flourescein.

His idea was that administration of the dye

followed by irradiation of the tumor produced an especially
great effect effect on the tumor because of the effect
of the irradiation on the dye.

A later report on seventy

cases was made by Copeman, Coke and Gouldesbrough (1929)
and a final one by Copeman (1931) on 120 cases.
three of these apparently recovered.

Twenty-

Mottram (1929)

tested the effect of flourescein and irradiation on
tumor tissue in vitro.

He found that the action was

purely a summation of the effects of the flourescein and
irrad.ia ti on.
Rossi (1928) included methylene blue with
sodium silicate and magnesium sulfate in the treatment
of inoperable tumors.

The results are inconclusive and

the value of the incltvidual substances impossible to
determjne.

Sugiura and Benedict (1929) studied the

toxic action in vitro of malachite green, methylene blue,
gentian violet and congo red on the Flexner-Jobling rat
carcinoma, the Sugiura rat sarcoma and the Rous chicken
sarcoma.

While of some value, in the order listed, the

authors did not seem

~articular1y
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impressed.

THE SPEC IPIC CONSTITUTIONAL TREATMENT OF CAJ'TCBR

VI
BIOLOGICAL PREPARATIONS
A. HORMONES AND TISSUE EXTRACTS
EXTRACTS OF THE SUPRARENAL GLANDS.--Anatomic and functional
differences between the cortex and medulla of the suprarenal gland are now well established.

While most prepar-

ations used in the treatment of cancer have been cortical
extracts, some have used medullary extract and others
mixtures.

Coffey and Humber, whose much publicized work

opened the controversy on the value of suprarenal cortex
extract in the treatment of cancer, hate published several
reports (1930, 1931) on their work.

It was based on the

theory that the normal secretion of these

structu~es

controls tissue growth and can destroy malignant tissue.
As far as it has been possible to determine, however,
Coffey and Humber have at no time reported the number of
cases treated, giving the information necessary for determining the percentage of cures, not have they given the
basis'they fave used for considering a case cured.

In-

asmuch as the reports by the originators of this method
of treatment is concerned, then, there is no evidence of
its value.

Animal

Tumors.~-Bischoff
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and Maxwell (1930, 1931)

employed eight preparations of suprarenal extract, including
that of Coffey and Humber, on rats with sarcoma 10 and
the Hyde carcinoma and found all to be without effect on
the indidence of regressions and the rate of growth of
the tumors.

Woglom (1931) treated mice bearing carcinoma

63 and sarcoma lBO with suprarenal extract taken from
rabbits treated with mouse tumor extracts and with a
preparation from normal rabbits.
effect.

There was no inhibitory

Sugiura (1931) used an aqueous extract of sheep

suprarenal cortex prepareo. by the methed of Coffey and
Humber tn the treatment of animals with the FlexnerJobling rat carcinoma, the Sugiura rat carcinoma, the
Bashford mouse carcinoma 63, a transplantable mouse
melanoma, and Rous chicken sarcoma, and spontaneous
mammary carcinoma of the mouse.

Subsutaneous and

intramuscular, single and repeated injections had no
curative, retarding or accelerating effect on the growth
of the tumor or on the duration of life of the animal.
Itami and McDonald (1930) could observe no effect on a
spontaneous mouse tumor from the preparation they used.
Reicher (1910) claimed adrenal in injected intratumorally destroyed mouse carcinoma and rat sarcoma,
while Uhlenhuth (1910) had found no therapeutic effect.
Lumsden (1931) used it with a serum injection to prevent
absorption of the serum.

Tamura (1934) treated rats

bearing the Flexner-Jobling carcinoma and rabbits bearing
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the Kato sarcoma with a variety of extracts of the suprarenal gland.

Large doses of the cortical preparatj.on

were slightly inhibitory, while adrenal in produced
distinct transitory acceleration of growth.

Sugiura

and Benedict (1930) investigated the effect of suprarenal
extract upon the Flexner-Jobling rat carcinoma and the
Rous chicken sarcoma.

They studied the effect of intra-

tumoral injection, distal subsutaneous tnjection and
application to the tumor cells in vitro.

They found that

intratumoral injection injibits small tumors completely
but has no effect on larger ones; that remote subeutaneous
injection has no effect, and that the Flexner-Jobling tumor
is partially destroyed and the Rous sarcoma unaffected
by application in vitro.

They concluded that any possible

value was limited to intratumoral injection.
Human.--Naame (1929) treated a group of patients
w:I th thyroid , liver and suprarenal extracts.
to six cases, two of which were clajmed cured.

He referred
M. Roussy,

in dtsctlssion, stated that no effect hall been produced
in any case he treated.

Livsic (1932) held that suprarenal

cortex is employed in the defense against cancer by way
of regulating lipoid metabolism, and he employed extracts
thereof in the treatment of human cases.

He gives reports

on two cases that were apparently benefttted.

Dominguez

(1931) treated thirteen patients with adrenal in and spprarenal products especially prepared and noted no improvement
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in any case.

Harris (1931) undertook a clinical study of

415 cases with malignant tumors who had received experimental injection of the Goffey-Humber extract.

There

were 264 known dead in fourteen months; of the remainder,
there was no evidence of any cures.

Ball (1931)

per-

formed autopsies on 116 cases of malignant disease,
eighty-nine of which had received experimental injections
of the Coffey-Humber extract.

No essential change from

that usually observed in the characteristics of malignant
disease in far advanced cases could be found in the tissues
of the eighty-nine cases treated.
PITUITARY AND OVARIAN HORMONES.--Animal Tumors.--A group
of Japanese investigators (Murohara, Motsuoka, Maeda,
and Bimento, 1930) found that the rate of growth of a
transplantable rabbit sarcoma was retarded and the incidence of metastases reduced by the administration of
follicular fluid.

They reported the same results from

large doses of thyroxin in potassium iodide ano from
thymoglandol.

Bischoff and Maxwell (1930), however,

treated rats with sarcoma 10 with the Alan-Doisy follicular preparation, corpus 1uteum extract, and three
splenic extracts without effect on the incidence of
regressions or the rate of growth in well controlled
experiments.

Later (1931), they reported on the use of

placental and pregnant urine

e~tracts,

thyroxin, synthalin

and parathormone on rats with sarcoma 10.
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All these

substances were ineffective.

Gruhzit (1933) treated rats

which had been innoculated with the Flexner-Jobling
carcinoma with anterior pituitary hormone extracted from
the urine of pregnant women.

There was no significant

difference in the course of the disease in the 124 treated
animals and the 110 controls.
of urine of

pre~ant

Gross (1932) used extracts

women and urine of women having

cancer, hormones of the anterior pituitary, human and
bovine placenta, and umbilical cord extracts on 321 mice
having the Vienna sarcoma.
specific results.

There were no consistent

In 1933, Maxwell and Bischoff treated

fourteen mice bearing the sarcoma 180 with pituitrin,
and noted no difference in the rate of growth in the
treated animals anc in the fifteen controls.

Krehbiel,

Haagensen, and Plantenga (1934) treated sixty animals
who had been inoculated with mouse sarcoma 180 with an
anterior pituitary hormone.

Forty-five died during the

period of observation of the experiment, and there was
no evidence of improvement in the fifteen survivors.
Tanzer (1936) reviewed much of the work done on the use
of hormones in the treatment of cancer and called attention to hazards arising from the difficulties of differentiating direct and indirect effects.

The indirect ef-

fects consist of malnutrition and sickness of animals.
To eliminate such hazards, he set up experiments in which
the tumor tissue was ex:t3osed directly to prolan extract
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in vitro, following which inoculation was made into the
host and a control inoculated into the same animal.

He

used follutein, a powdered prolan prepared by the method
of Aschheim and Zondek and mouse sarcoma 180 and S37.
Nith the former, there was no evidence of inhibition or
acciteration of growth, while with the latter, there was
slight inhibition of growth.
HUI!lan.--Susman (1931) postulated some increased
secretion of the anterior pituitary in cases of malignant
disease and sought to reduce this with pituitrin and
theelin.

Since abundant carbohydrate in the diet of

mice promoted the development of irritation
the carbohydrate intake was restricted.

c~r~inoma,

Reports on seven

treated cases claim some improvement during the short
period of observation.

Ishihara (1934) was convinced

that Wharton's jelly was an important structure, having
an endocrine function, and that a similar hormone is to
be found in the jelly between the inner and_ outer egg
integuments of the placenta and in the corpus luteum of
the ovary.

He reported on the use of this substance,

which he called "P. O. U.ry (placenta-ovary-umbilicus)
hormone, in more than 200 cases, many of which appeared
cured.

Several have not relapsed in three years.

number of case reports are given.

A

Stewart (1932) gave

case reports on four patients treated with pituitary
extracts without any beneficial effect, and Riches and
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Kremer (1932) treated nine cases by the method of Susman,
all their cases following the 'fumal course of the disease
with no regressions or prolongation of life.
MISCELLA}I~EOUS.

--Cioffari and :?iccaluga (1926) treated

mice before, after, ana before and after inoculation
with a tumor with insulin.

Those treated both before

and after inoculation showed some retardation of growth
of the tumor, living ten to fifteen days longer than the
other animals.

No regressions occurred.

Boivin (1927)

treated one rabbit with tar cancer with insulin without
beneficial effect.

Fichera (1933) beleived cancer due

to a disturbance of the tissues and organs which regulate
cytolysis and sought to cure it by administration of a
preparation containing extracts of the organs he found
to increase cytolysis.

He

regulating organotherapy".

c8~led

this method "lytic

Over 300 cases have been treated

of which over 100 were inoperable and ray-resistant cases
with recurrences Rnd metastases.

Using only the

bi~-

logic oncolytic regulating therapy, complete regressions
occurred in nine percent of the aases and permanent
stand-still of the tumor growth was observed in eight
percent.

Schulte and Lutteken (1935) treated sixty-one

patients by FicheraTs method nnd found none in any way
improved.

They comment that this is the usual finding

of all except Fichera.

Konsuloff (1934) treated mice

bearing the Ehrlich tumor with a mixture prepared from
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a splenic extract and alkaline earth metals.

Of the 120

mice treated, slowing of growth occurred in fifty to eighty
percent.

As the computed volumes varied greatly in the

treated animals and in the controls, they wisely refrained
from reaching any definite conclusions from their results.
Stmpson and Marsh (1931) found karkino1ysin, a thymic
extract, to be without value in the treatment of a spontaneous mamMary carcinoma of the mouse.

Rohdenburg and

Bullock (1915) noted that insufficient or exoessive
secretion of the thyroid, thymus, ovary, adrenal and
pancreas had been thought causes of cancer, and extracts
of these glands used in treatment.

They reasoned that

if functional changes are accompanied by histologic
changes, controlled observation of the histoloty of these
glands in animals bearing spontaneous tumors might throw
some light on their role in the cause and cure of cancer.
As a result of this line of thought, they examined the
liver, kidney, spleen, pancreas, ovary, thymus, pituitary,
parathyroid, thyroid, and adrenal of mice with spontaneous
tumors and of controls.

Their was no signiflcant differ-

ence In these organs in the affected anlmals and the controls.

Maisln and Pourboix (1935) reviewed the history

of work with growth-promoting and. growth-inhi bi ting
substances extracted from normal organs.
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B. VENOl.dS

It has been established that the venoms of some
snakes have an analgesic action when administered in
proper doses to cancer patients.

The value of this

method of producing analgesia as compared with the more
standard procedures is disputed.
published on this

~atter

Many papers have been

with no reference to cure of

cancer, but as it was introduced as a method of cure,
there have been numerous reports seeking to establish its
value therein.

Only those dealing with the latter phase

of the subject will be considered here.

Attention

should be called, however, to the fact that besides the
negative reports, the many instances in which it has been
used as an analgesic without cure resulting detracts
from the possibility of its having any curative value.
Animal Tumors.--Essex antt Priestly (1931)
investj.gated the effect of rattle snake venom on the
Flexner-Jobling rat carcinoma and. founel it to be of no
curative value.

Grasset and dse I,egneri s (1934) found

no constant inhibitory effect in vivo or in vitro on the
Rous chicken sarcoma.

The transitory effect on melanomas

in an Angora goat and a horse were not maintained, perhaps
because an anti venom was produced.
Human.--Piton (1934) treated fifty cases with
only partial relief of pain and occasional transitory
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arrest of the growth.

He points out that Professor

Billard, in about 1913, claimed success in treatment of
one nase of carcinoma with viper venom.

Lavedan (1935)

treated fifty-one cases of histologically c')nfirmed
cancer with cobra venom.

Some cases received intramuscular

injections, while others were treated by injection directly
into the tumor.

From his results as well as from those

of others whose work he revfuews he concludes that the
relief from pain is irregular and inconstant, mapy
patients experiencing no relief at all; that the action
on tumors in man is nil; and that under these cond:itions,
its use should be reserved for the rare cases in which
morphine is ineffectual.
C. BACTERIA AND TT{EIR GROWTH PRODUCTS

It had long been noted that patients with cancer
were often improved markedly following an attack of an
acute febrile disease, especially erysipelas.

Many of

the cases in which spontaneous regression of established
neoplasms had been reported had given a history of such
attacks of febrile disease.

Fehleisen (1883) discovered

and proved the etiology of erysipelas and inoculated
seven patients having advanced and hopeless cancers with
Streptococcus erysipelas.

Of the six in which the disease

developed, the neoplasm became much improved jn three.
This is the earliest available record of the use of
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specific constitutional methods of treatment of cancer
in modern times.

Lassar used sterile filtrates of

Streptococcus erysipelas cultures in the attempt to treat
human malignant disease in 1891.

At the time, the

method had not been placed 1J.pon an experimental basis,
but soon afterwards Spronck (1892) treated animals bearing
spontaneous neoplasms with killed cultures.

While the

results of these early works were not especially good,
they led others, notably Coley, to investigate this field.
Animal Tumors.--Spronck (1892) treated animals
bearing spontaneous tumors with killed cultures of
Streptococcus erysipelas.
a few cases encouraging.

He considered the results in
Beebe and Tracy (1907) made

multiple inoculations of a transplantable lymphosarcoma
iEma eleven dogs.

Both the sterile culture and the fil-

trate of Staphylococcus pyogenes aureus, Streptococcus
pyogenes, Bacillus prodigiosus, and Bacillus coli communis were used intratumorally and by injection distal
to the tumors.

Some of the tumors regressed partially

and there were some complete recessions.

Then, for a

long peri0d during which Coley's toxins were betng used
in a few human cases, interest tn the experimental aspect
of this subject lagged, until revived in 1931 by the
work of Gratia and Linz.
They treated transplanted liposarcoma of the
guinea pig with filtrates of Bacillus coli and obtained
62

hemorrhage and liquefaction in some tumors.

Shwartzman

had noted a skin reaction to meningococcus filtrate in
a large percent of animals bearing neoplasms, which he
considered of value as a serological method of diagnosis
of cancer.

In 1932, he (Shwartzman and Michailovsky)

reported some complete regressions of mouse sarcoma 180
following administration of meningococcus filtrate.
Later (1935), he studied the effect of spontaneous and
induced infection on the development of mouse sarcoma
180.

Bacillus enteriditis infection in 610 mice prevented

the occurrence of growth of inoculated neoplasm in
twenty-three percent of the animals at the end of the
second week.

Staphylococcus aureus was of no value, but

Bacillus enteriditis (rough) caused complete regression
of the tumor in eight of twenty aniMals.
aureus culture filtrate was also

Staphylococcus

inacti~e,

but the sterile

filtrate of a culture of Bacillus enteriditis gave results
similar to those of the live organism.

Shear (1935), after

studying a very large group of chemicals in the treatment
of cancer, c!mcluded that his best results were wlth
badterial filtrates.

He tested agar washings of menin-

gococcus filtrates with results which he considered
encouraging, a few of the growths completely and permanently receeding.

He stated that other experiments which

were soon to be reported had given favorable results in
upward to 100% of the treated animals.
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Duran-Reynals

(1933) undertook the study of the reaction of tumors to
blood carried bacterial toxins.

With Bacillus coli

toxins he found rapidly growing transplantable malignant
tumors of rats and mice to be susceptible, while slow
growing were not.

Later (1935), he treated fifty-two

mice bearing proven mammary carcinoma with very toxic
agar washings of human or mouse typhoid bacilli or both.
Six were entirely inhibited, three cured and three
recurred.

Results were better in small tumors than in

large ones.
Torrey and Kahn (1927) used the proteolytic
enzymes of Bacillus sporogenes and Bacillus histolyticus
to treat white rats inoculated with the Flexner-Jobling
carcinoma.

The former was dropped because of the un-

satisfactory results obtained.

Use of the live Bacillus

histolyticus contained in whole broth cultures caused
very energetic digestion which was not
tumor.

li~ited

to the

In their attempts to prepare a satisfactory

sterile filtrate, they Modified the medium, culture
method, and concentration of the proteolytic ferment.
Their best results were with a certain strain of the
organism grown for twenty-four hours on a three to four
percent peptone meat infusion broth by the Huntoon method
with added fresh defibrinated blood, especially where a
few living organisms were added.

Fifty to seventy-five

percent were cured where the skin was not too much in-- 64

volved.

As the injections were intratumoral, however,

the method does not lall clearly into the field of
constitutional treatment.
Spontaneous mammary carcinoma of the mouse
were not benefitted by Tuberculin (Simpson and Marsh,
1931).

Gye (1935) used ensol (see Connell, below) on

appropriate mice and found it to be worthless.
\

Roskin

and Monanowa (1935) experimented with the use of several
protozoan infections in the treatment of tumors of
animals.

They found that infection with Spironema duttoni

or treatment with baoterial endotoxins ("pyrifer", from
non-pathogens of the coli type) had no effect on an
unspecified type of transplantable mouse carcinoma, and
that Trypanosoma equiperdum was ineffective against an
unidentified guinea pig tumor.

Infection with Schizo-

trypanum cruzi and injection withe the sterile endotoxin
retarded the growth of the

~ouse

tumor.

Forty-five mice

were simultaneously inoculated with the tumor and infected
with the organism; thirty growths disappeared and fifteen
were retarded in growth but all the animals subsequently
died of the infection.

Forty animals were treated with

the endotoxins alone; twenty-four grew and of these the
rate of growth was considerably smaller in the treated
group than in the controls.
HUMan.--Lassar (1891) was not impressed by the
results he attained in the treatment of two cases of
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human cancer with sterilt:f filtrates of Streptococcus
erysipelas.

Coley (1891), however, noting the obser-

vations of others regarding the results of accidental
ot deliberate production of erysipelas in cancer

p~tients,

treated several such patients by inoculation with the
disease and. considered his results sufficiently good to
warrent further trial.

By 1893, he had collected records

of forty-seven cases of cancer patients (ten of which
were personal cases) that had been accidentally or
deliberately inoculated with Streptococcus erysipelas.
He concluded that the curative effect in some cases was
an established fact; that sarcoma Patients were more
often benefitted than carcinoma patients, in a ratio of
about three to one; that the treatment was not dangerous;
and that the effect was due to the systemic action of
the toxins of the organism.

A note appended to this

article stated that the toxins of the organism combined
with those of Bacillus prodigiosus were being tried and
would be reported soon.
known as

Co~eyTs

toxins.

This latter combination became
Seyeral reports were made in

the following years by Coley as well as by a number of
other physicians who had tried the Coley treatment.
While some denied any value whatever in the method,
the majority found that the treatment was of some benefit
in a small percentage of cases.
late results in his

ear!~

Coley reported on the

Buceessful cases as we&l as on
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the successful cases reported in the literature by 1906.
Twenty-four of Coley's cases were living and well three
to thirteen years, and twenty-seven cases of other
physicians were living and well three to twelve years.
At the time, only sarcoma were considered sufficiently
benefitted to warrent treatment.

Coley's toxins were

admitted to New and Uon-official Remedies in 1910.

The

council's report stated that four to nine percent of the
cases treated were cured.

The product was reconsidered

and retained by the council in 1934 following consideration
of numerous pro and con reports on its value.

The council

concluded that use of the mixed toxins may prevGnt or
retard recurrences or metastases, that an occasional
cure may result in an otherwise hopeless case, and that
the value is probably limited to tumors of entodermal or
mesodermal dirivation, especially bone tumors without
marked osteoplasia.

Coley's later reports (1927, 1928,

1931) dealt for the most part with bone tumors.

His

results show that irradiation or amputation alone cannot
be expected to cure cases of bone sarcoma, but that
toxins and amputation cure a large percent of cases
including many in which new bone formation occurs, that
the toxins and irradiatj.on cure some cases in which new
bone formation does not occur, and that toxins alone
have cured a few cases.
(192 7

,

The case of Christian and Palmer

1928) is an example of a recurrent myelosarcoma
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(endothelial myeloma?) successfully treated by toxins
alone.
with

Campbell (1935) analysed a group of 125 patients

pri~ary

malignant bone tumors, fourteen of which were

living and well five years or more.
sarcoma and four were non-osteogenic.

Ten were osteogenic
Coley's toxins

were used in four cases,--one case of vary malignant
osteogenic sarcoma was living and well four and one
haif years following amputation and toxins; three cases
of endothelial myeloma (Ewing's tumor) were living and
well four, five and eight ya,ars following treatMent with
Coley's toxins combined in each case wlth amputation,
irradiation, or both.
Coley (1928) reported the end results in the
treatment of thirty-nine cases of Hodgkin's disease
and fifty-eight cases of lymphosarcoma, where the mixed
toxins alone or the toxins combined wjth irradiation were
used.

Three of the former and six of the latter were in

good health three or more years.
Connell (1935) treated a group of animals and
patients with a solution prepared as a filtrate of the
growth products of Bacillus histolyticus grown on cancer
tissue of the same type as the growth to be treated.
Although the statistics were not given and the period of
observation was short, the author concluded that the
substance was valuable.
solution).

He called it ftensol lf (enzyme

Pearl, Sutton and Howard (1929) treated
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seven cases wi th subcru:traneous injections of tuberculin.
They thought the size of the t"nmors to be reduced and the
life of the patients prolonged, but claimed no cures.
D.

MISCELLAi~EOUS

Whitehouse (1927) reported a case of ovarian
carcinoma with peritoneal metastases treated by transfusion of blood of a woman ten weeks pregnant and transfusion of irradiated ascitic fluid.
followed.

Intensive regression

Dziembowski (1930) treated 120 patients by

injecting irradiated autogenous blood into the tumor and
intravenously.

At the time the results were not discussed,

but in a later report (1931), cures were claimed in a
few cases.

Hyde (1935) reported on the use of irradiated

autogenous blood in advanced cases of cancer following
incomplete extirpation of the growth.

The injection is

made intravenously after irradiation of the blood.

The

number of cases treated was not given nor were the number
of cures, but the author refers to several cases greatly
benefitted.
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THE SPECIFIC CONSTITUTIONAL TREATMENT OF CANCER
VII
MISCELLA1TEOUS :METHODS

FEVER TRERAPY.--The classification of certain methods of
treatment of cancer presents
simil~r

so~e

difficulties because

methods differ in the theories of their action.

Thus, methods will be included here that may seem to
belong elsewhere, but the substances herein reviewed
are arbitrarily classified, for the most part, according
to the theory of action advanced by the various indivdual investigators.

·n no case, however, is a single

substance or method considered under two topics because
of differences in the theories of acti0n advanced.
Animal Tumors.--Rohdenburg and Prime (1921)
studied the effects of combined heat and radiation on
transplantable tumors in vitro and on spontaneous tumors
in vivo.

They found that low degrees of heat continued

sufficiently mong were 100% effective in killing cancer
cells in vitr~nd
that heat combined with irradiation
--\
extended the usefulness of the latter.

They note that

reports on fever treatment of malignant tumors had been
made years previous by Loeb, 1912; Jensen, 1903; and
Clowes, 1906.

Woglom followed this with a study of body

temperature and tumor growth in 1924, but because the
results were negative, they were not reported until 1934,
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by which time some favorable reports had accumulated.
Woglom investigated the effect of febrile temperatures
on seventy-seven rats with the Flexner-Job1ing carcinoma
or the Jensen sarcoma and on thirty-nine mice with carcinoma 63 or sarcoma 180.

Eighteen experiments were

performed in which different temperatures and different
exposure times, varying from thirty-one to a total of
348 hours, were employed.

No adverse effect upon the

tumor was noted in any case.

WaD::er (1935), who had

previously found that eXDosure of rat tumor 256 to a
temperature of 111.4 0 in vitro uniformly prevented takes
on subsequent implantation, kept twenty-six animals at
that temperature for twenty minutes.

The tumors from

each of the six rats that survived the twenty minutes
(but which died within eight hours) were implanted into
eight rats at the time of the death of the animal

While

controls grew in each instance, only two of the forty-eight
treated tumors grew.

Thirty minutes at 109 0 four ti~es

had no effect on the tumor.

When the temperature was

maintained at 111.4 0 by means of a high frequency apparatus, none of the thirty-:ftve animals survived twenty
minutes.

:?racttcally all of the tumors had been devi tal-

ized at the time of the death of the animal as noted by
failure to take on implantation.
Human.--Braunstein (1931) inoculated six patients
with the tertian malarial parasite and noted distinct but
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transient regression of the tumor.

Warren (1935) under-

took a rather extensive study of the effect of artificial
fever on hopeless tumor cases.

He studied the effects

of febrile temperature on animal tUmors in vitro and
l~

vivo; the temperature gradient during local and general

heating; and the effects of prolonged and mainta:i.ned
generalized artificial fever in hopeless
metastases.

tlli~or

cases with

His in vitro experiments showed that there

is a definite lethal time-temperature for malignant tissue
as there is for the gonococcus and the Treponema pallidum.
Animals di.d not endure the necessary temperature for the
time indicated by the in vitro experiments to be the
thermal death time.

In h5.s human cases, he first used

diathermy and later radient energy, raising the temperature
to 41.5 0

•

Of the thirty-two cases treated, thirty were

proven malignancy.

The obseFvatj.on period extended

twenty-three months, and all but three relatively recent
cases had died., with one exception, within thirteen months.
Doux (1935) reported a case of proven osteogenic sarcoma
of the clavicle hiving deep X-rRY and eight fever tre.at~ents

at weekly intervals, at which times the rectal
~

temperature was maintained at 105-106 0 for five hours.
Steady and continnnus improvement ensued and the patient
was working and aDparently well at the end of an observation period of slightly more than a year.

In discussion,

Dr. Bierman stated that a case of cancer of the lung was
72 --

alive three years following fever therapy.
A book published by Wiley Meyer in 1931 is
interesting from the standpoint of fever therapy in cancer,
but as no new experimental work is presented, it is not
discussed here.
GASES.--Campbell (1931) makes a critical review of the
use of gas mixtures in cancer therapy.

Inhalation of

gas containing a high percentage of oxygen as recommended
by Campbell and Cramer; increased atmospheric pressure
studied by Fischer and 5% carbon dioxide in oxygen reported by Fischer-Wasels as well as a number of others
were reviewed.

He concludes that there is no evidence

of any influence on tumors or their metastases.
(1934) treated rats bearing the Raffo sarcoma.

DeAlmeida
Seven

to twenty-three percent of the an:i'"'1als we.Fe cured by
oxygen at one to eight atmospheres treated at twenty
minute to twenty-four hour intervals.
co~'letely

SOMe tumors were

destroyed, but there was a heavy mortality

in the treated animals.
WATER BALANCE.--Shear has undertaken a number of fundamental studies of the chemistry of tumors with view to
discovering' a method of chem;cal treamment.

Reference

has already been made to his studies of the role of
sodtum, potassium, calcium, and magnesium in cancer and
to the findings as to the effect of bacterial filtrates.
The latter study (1935) was part of an investigation of
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disturbances of fluid exchange on transplantable mouse
tumors.

Fe hael studied such matters in in vi tro exper-

iments (Shear and Fogg, 1934) and the present paper
reports results of tests of the methods in vivo on mice
bearing sarcoma 180 or carcinoma 63.

His results with

deprivation of water, use of diuretics and massive
bleeQing were negative, so he attempted to alter the
permiability of the cancer cells.

To do this, the following

substances were administered with the results noted:
histamine, tyramine, trimethylamine, indole, skatol and
choline with negative results; pneumococcus anltbody
and soluble specific carbohydrate, with some effect-hemorrhage; bacterial filtrates, as have been noted, with
striking results; lipoid solvents !iI,neluding alcohol,
ether, chloroform, carbon tetrachloride, bile salts,
and lecithin with negative results; sodium oleate with
some effect; fibrin, sodium citrate and heparin with
negative results; high protein diets and injection of
agar, acacia, altg albumen, and serum albumen caused a few
recessions; repeated horse serum injections into seventeen
animals caused three complete recessions.

The author ad-

mitted that many of the substances used here may have
actions whtch are not entirely depeno_ent on their effect
on fluid exchange, but he considered this the most important action of each for reasons given.
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VIII
DISCUSSION
It seems desirable to discuss the substances
and

~ethods

value.

reviewed in an

atte~pt

to estimate their

But before entering into a discussion of the

individual sUbstances employed. certain facts must be
pointed out.
Essential data are not given in many reports,
making it impossible to evaluate substances in the light
of any preconcieved criteria, such as those of Weil or
of the health organization of the JJeague of Nations.
But of the manY'::'1substances considered, by far the largest
share can be dismissed without detailed analysis because
of glaring lack of adequate scientific evidence of effectiveness.

In such cases, we must take the attitude

that S substance is of no value unJess proven so by
scientific observations, that is, the burden of proof
rests with those claiming effectiveness.
The significance of negative results is important.

Where such results with identical compounds are

overwhelming, especially where there have been few
positive results reported or where the previous reports
have arrived at positive conclusions without justification,
we must conclude that the SUbstance is without value.
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However, as has been pointed out by Marsh and

Si~pson,

negative results with a single compound of an elemant
and under a narrow range of experimental conditions
do not establish the lack of value of that element,
for variation of the compounds used or of the details
of the

experi~ent

might yield different results.

Thus,

conclusions must be limited to the circumstances of the
experiment, except inasmuch as they yield suggestions
for other possible useful experiments.
The purpose of all work on methods of consti tutional i;reatment of cancer is to dj.scover a substance
that may be used successfully in human cases, thereby
reaching beyond the present limits of surgery and irradiation.
are,

Successful results with animal experiments

the~efore,

valuable as leads, pointing to those

substances which may prove of value in human cases.
This useful aid makes possible the investigation of a
great many substances and should be employed in every
case before human material is used.
Of the me.tallic preparations, lead and gold
seem to merit consideration.

While most of the animal

experiments with lead compounds have been negative,
the results of Collier and Krause with complex organic
compounds of lead are moderately successful and further
work with them is indicated.

The principal claims are

made for lead in the clinical field, much work having
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been done with human subjects.

All that can be said is

that some observers have reported five to ten percent
cures in otherwise hopeless cases, while others have
been unable to note any useful results whatever.

One

can hardly reach any conclusions as to-its value is view
of such markedly conflicting reports, and further work
is indicated, probably using some compound whose effectiveness can be established by animal,experimentation.
No favorable experimental work haA been done on gold,
but in view of fichsner's reports of human cases, further
work should be undertaken.

The results with the remainder

of the metals are entirely unsatisfactory, and as far as
evidence at present is concerned, one may conclude that
they are entirely without value.
Of the non-metallic inorganic compounds, those
of selenium and arsenic merit consideration.

The sole

claim of the former rests with the unconfirmed observations of Todd, and its value is inconclusive until
further work is done.

Eggers results with tetramethyl

arsonium gluconate show it to be clearly the most effective substance yet produced in the treatment of
aniMal tumors.

His results, of counse, await confirmation

and trial in human cases to establish the value of his
compound.
Results with most of the organic compounds
including a group of dyes have been most disappointing.
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Some effect has been noted with amino acids and colchicine,
but these await confirmation.

While hormones have been

rather generally discredited, the results of Ishihara
with P. O. U. hormone should be checked.
Some striking effects have been produced by
bacterial growth products in aniMals.

Especially has

this been noted with filtrates of the meningococcus and
Bacillus enteriditis, employed by Shwartzman; the meningococcus filtrates used by Shear; and Bacillus coli and
typhosus used by Thlran-Reynals.

Coley's toxins have

stood the test of time and are the sole chemotherapeutic
cancer treatment havtng official recognition.

While thier

field of usefulness is liMited to sarcoma, especially
those of the bones, a definite small percentage of cases
are cured or greqtly benefitted by their use.

Their

effectiveness cannot be denied, but they are effective
in such a small percentage of the cases, that they cannot
be considereo specific.
Marked beneficial effect was noted by two
investigators working separately with irradiated autogenous blood in human cases.

Further work with this

method is indicated.
At present, any possible value in fever therapy
seems improbable.

Some thorough, well controlled exper-

iments show that the thermal death time of a group of
tumors exceeds t2at of the hosts, and human work has
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been quite unsuccessful.
therapeutic action.

Gases have shown very little

The water balRnce experiments of

Shear were negative except for those in which bacterial
growth products were used, these having already been
discusseo_.
Certain general criticisms of the work reviewed
may be made.

These are:

reports on experiments in which

too few subjects, human or animal, were used; failure to
employ controls in numerous of the animal experiments;
failure to give information necessary for independent
evaluation of results; use of combined forms of treatment
which renders evaluation of the incti vidual substances
impossible; and reaching conclusions which are broader
than the results of the experimental work justify.
In agaln examining the reports reviewed, it
C8.n safely be concluded that, while some substances
have undoubtedly produced cures in a small portion of
the animal and human tumors treated, no method has so
far been proven effective in the constitutional treatment
of cancer.

There are a number of sUbstances which are

quite promising and on whtch further evidence should be
gathered.
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IX
SUMMARY

(1). The need for and rational of specific
constitutional methods of treatment of cancer is presented.
(2). The history of the subject is given.
(3). The substances and methods which have been
used in animal and human cancer are classifted and their
results reviewed.
(4). General criticisms of the investigations
reviewed are made.
(5). Some sUbstances have been shown to have
cured otherwise hopeless cases of cancer, and early
results with a few sUbstances suggest that they may
eventually be proven of value.
(6). There is at present, however, no proven
effective specific constitutional treatment of cancer.
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